Skip to main content
Caplight Logo









Primaa

Primaa

Private
ParisHealthcare & Life Scienceshttps://primaalab.com/

Last Round

VC Round

Oct 29, 2025

Total Funding Raised

$2.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Primaa is a MedTech company that develops an AI-based software platform for automated and accurate histological diagnoses, designed to assist pathologists in cancer detection.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologycancer diagnosticscomputational pathologyAI pathologyAI cancer detectionbiomarker detectionmedical imaging AIpathology softwarediagnostic AIwhole-slide imagingsoftware as a medical deviceSaMDbreast cancer AIskin cancer AIdeep learningCE-IVDR certificationLIS integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Primaa Comparables

Compare Primaa with similar companies based on industry and business-model similarity.

Primaa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stratipath
88%
MindPeak
88%
Datexim
85%

Primaa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 29, 2025
VC RoundNov 18, 2024
SeedOct 11, 2019

Key People

Founding team and executive leadership

Marie SOCKEEL

Co-Founder and Chief Medical Officer

Founding Team

Stephane Sockeel

Chief Scientific Officer and Co-Founder

Founding Team

Fanny SOCKEEL MASSART

CEO & Founder

Founding Team

Hugo Watel

COO

Executive Team

Primaa Investors

Notable investors and investment history

Primaa investors
InvestorRounds
Super CapitalVC Round
Elaia PartnersVC Round
Entrepreneur InvestSeed
Leia CapitalVC Round
SWEN Capital PartnersVC Round
Angels SantéSeed
50 PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 177% MoM, reaching 3.4K.

  • Oct 29, 2025

    Raised $8.15M from Elaia Partners, SWEN Capital, and others.

Primaa Filings

Explore SEC and related filing metadata, where available.

Primaa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Primaa's valuation, stock price, and market status.

Is Primaa a public or private company?

Primaa is a private company.

What is the current stock price of Primaa?

Primaa is a private company with no public stock price. No recent secondary market data is available.

How much is Primaa worth (valuation)?

Valuation information for Primaa is not publicly available.

Can I buy Primaa stock?

Primaa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Primaa's last funding round?

Funding round information for Primaa is not publicly available.

Who are the main investors in Primaa?

Investor information for Primaa is not publicly disclosed.

Will Primaa IPO soon?

No public IPO plans have been announced for Primaa.

How can I track Primaa secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Primaa's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range27
Year Founded2018
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?